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Abstract Toll is a Drosophila membrane protein related in se- 
quence to the mammalian platelet glycoprotein 1B and to the 
interleukin-1 receptor. It mediates a signal transduction pathway 
leading to the development of dorsoventral polarity in the Droso- 
phila embryo. In this paper we show that a constitutively activated 
mutant receptor, ToH10B, is processed into a distinct isoform of 
slower electropboretic mobility when compared with the wild type 
molecule in both cell lines and the embryo. The wild type protein 
can also be processed into this form if over-expressed but in the 
embryo is present as the smaller species. We show that the de- 
crease in the mobility of TolI10B and over-expressed wild type 
receptors is caused by altered patterns of Nqinked glycosylation 
and that both forms are secreted to the cell surface. On the basis 
of these results, we propose that the TolIIOB receptor is unable 
to associate with a limiting co-factor which when bound directly 
or indirectly masks supplementary N-linked glycosylation sites. 
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I. Introduction 
The Drosophila Toll protein is a membrane receptor equired 
during pre-cellular embryogenesis for the generation of dorso- 
ventral polarity (for a review see [1]). The cytoplasmic region 
of Toll is related to that of the type 1 interleukin-1 receptor [2,3] 
and it is likely that the cellular signalling pathways mediated 
by the two receptors are very similar at the biochemical level 
[4]. The extracellular domain of Toll contains two blocks of 
leucine-rich repeats (LRRs) flanked by cysteine-rich sequences 
[5]. In the related receptor platelet glycopreotein 1 B, the cyste- 
ine-rich sequences form two sets of disulphide bonds which are 
required for binding of the ligands thrombin and von Wil- 
lebrand factor [6,7]. Genetic studies have identified a mutant 
form of Toll, Toll lOB, that is constitutively activated [3]. The 
activating mutation changes a cysteine residue to tyrosine in the 
sequence flanking the second block of LRRs. Thus in the 
Toll l0B receptor the conformation of the second cysteine-rich 
sequence may be disrupted in a manner which mimics the bind- 
ing of an activating ligand. The extracellular domain of Toll 
contains eighteen consensus ites for N-linked glycosylation 
and it is known that at least some of these sites are modified 
[8,91. 
Previously we reported that all the components of the signal 
transduction pathway are present in the embryonic ell line SL2 
and that the pathway is effectively activated by inducing the 
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expression of the TolI10B receptor [10]. We now show that the 
Toll l0B receptor is glycosylated to a greater extent than the 
wild type molecule in these cells. The hyper-glycosylated form 
is also produced by embryos derived from mothers carrying the 
Toll l°B gene and when wild type Toll protein is over-expressed 
in cell culture. 
2. Experimental 
2.1. Establishment and maintenance of cell lines 9A and SLTLIOB 
The culture and manipulation of SL2 cells and derivatives has been 
described [5]. For cell line 9A, SL2 cells were transfected with 10/~g of 
F9-Toll plasmid [5]. The cells were selected by culture in geneticin G418 
and then cloned by limiting dilution. For SLTL10B cells, SL2 cells were 
transfected with 2/lg of F9-TolI10B [10] and selected with 1.5 mg. ml i 
of G418. 
2.2. Preparation of cell and embryo protein extracts 
SL2 cells were collected by centrifugation (1000 x g) and extracted 
into T lysis buffer (50 mM Tris-HC1, pH 8.0, 150 mM NaC1, 1.0% 
NP40, 0.5% sodium deoxycholate, 0.1% SDS) supplemented with PiC 
(1 mM phenyl-methyl-sulphonyl fluoride, 0.014 mg/ml pepstatin and 
0.01 mg/ml eupeptin). Embryos were collected from apple juice agar, 
dechorionated in half-strength bleach (2 min), washed and extracted 
into T lysis buffer supplemented with PiC. Protein content in the 
extract was estimated using a dye binding assay. To prepare xtracts 
from Tolll°Sl+ embryos, females that were either Sb Sere or phenotyp- 
ically normal were selected from a stock of the genotype TI roB, mwh, 
e/TM3, Sb Ser," T(1;3) OR60 (Tubingen stock K317). The selected 
females were placed in small population cages and were sterile as no 
embryos hatched into larvae. 
2.3. Western blotting of proteins 
Protein extracts were separated by SDS-PAGE. After the electropho- 
resis, the gel was soaked in transfer buffer (25 mM Tris, 90 mM glycine, 
20% methanol) for 10 min. The nitrocellulose membrane (Hybond-C ÷, 
Amersham) and 3 MM paper (Whatman) was cut to the exact size of 
the gel and moistened in transfer buffer. A semi-dry blotter (ATTO) 
was used for transfer and a sandwich was constructed according to the 
manufacturer's instruction using six papers for each side. Transfer was 
performed at a constant voltage of 20 V overnight at 4°C or 32 V for 
90 min. For blocking of non-specific binding sites, the membrane was 
incubated with 7 mM Na2HPO4. 3 mM NaH2PO4, 150 mM NaC1, 0.1% 
Tween 20 (PBTw) (0.2 ml/cm 2of membrane) supplemented with 10% 
dried milk for 1 h at room temperature or overnight at 4°C. The blot 
was rinsed once with PBTw and incubated with 0.1 ml/cm 2 of the 
primary antibody solution (see [5] (1120,000 dilution) for 2 h with 
agitation. The primary antibodies were diluted with PBTw supple- 
mented with 1% dried milk. The blot was washed with PBTw three 
times for 5 min each and then incubated with the secondary antibody 
(l/1000 dilution) for 2 h. Since the Drosophila cell extract was found to 
contain several avidin binding proteins, HRP-conjugated anti-rabbit 
antibody (Dako) was used to obtain less background. Following three 
washes of 5 min in PBTw, the proteins were visualised by the ECL 
(enhanced chemiluminescence) system (Amersham).The blot was incu- 
bated in the substrate solution for 1 min with shaking and then the 
substrate solution was trapped by two sheets of 3 MM paper placed on 
a sheet of Dow 'Saran' film and the blot was superimposed on these 
papers with the blotted side up and covered with Dow 'Saran' film. By 
capillary action from the paper, the ECL reaction continued uring 
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exposure. The blot was exposed to Fuji NIF X-ray film for 5-60 s 
depending on the intensity of the signal. Embryonic protein extracts 
were prepared as previously described [11]. 
2.4. Deglycosylation fproteins 
Cell extract was prepared from 107 cells and dialysed against PBS 
supplemented with Pic in a Centricon-10 ultra-filter. In order to reduce 
aggregation of the protein, 0.1% Triton X-100, was included. Samples 
were divided into two and endoglycosidase F (6 U/ml; Boehringer) and 
PiC was added to one of them. The enzyme solution used was actually 
a mixture of endoglycosidase F and glycopeptidase F. The deglycosyl- 
ation reaction was carried out at 37°C overnight and stopped by adding 
SDS-PAGE sample loading buffer followed by boiling for 5 rain. Pol- 
ypeptides were fractionated by SDS-PAGE and identified by Western 
blotting. 
2.5. Biotinylation of surJace protein 
Specific labelling of surface protein was achieved by NHS-biotinyla- 
tion. In this method, cells are incubated with n-hydroxysuccinimide 
ester (NHS)-biotin which reacts covalently with the e-amino group of 
lysine residues [12]. During labelling, endocytosis i  arrested by cooling 
on ice and therefore only surface protein is covalently linked with 
biotin. Proteins are fractionated by SDS-PAGE and transferred onto 
a nitrocellulose membrane. Biotinylated polypeptides are visualised by 
probing the transfers with HRP-conjugated streptavidin. By including 
an immunoprecipitation step before SDS-PAGE, surface localisation 
of a specific protein can be monitored. The day before the experiment, 
logarithmically growing cells were seeded at a concentration of 
2 x 106cells/ml on a 24-well plate (1 ml/well) and incubated overnight 
at 26°C. In this condition, most of the SL2 cells stick to the bottom of 
the well. For Toll protein biotinylation, clones were heat-shocked at
37°C for 30 min and recovered at 26°C for 1 h. Cells were washed gently 
several times in PBS supplemented with 1.0 mM MgCI 2 and 0.1 mM 
CaC12 on ice. The biotinylation was performed by incubation in the 
same buffer containing 1 mg/ml of NHS-biotin on ice for 30 min. 
NHS-biotin can be dissolved in dimethyl sulfoxide at a concentration 
of 100 mg/ml and stored at -20°C. In order to quench the free NHS- 
biotin cells were washed with M3 media three times. Biotinylated cells 
were harvested by pipetting and collected by centrifugation. To prepare 
cells lysates, the media was aspirated and the cells solubilised in 'I' lysis 
buffer (50 mM Tris-HC1, pH 8.0, 150 mM NaC1, 1.0% NP40, 0.5% 
sodium deoxycholate, 0.1% SDS) supplemented with PiC. Insoluble 
material was removed by centrifugation (14,000 z g, 10 min). Antibody 
was added (l/40th dilution) and the lysate incubated at 4°C overnight. 
Then 30/11 of a 50% slurry of Protein-A Sepharose was added and the 
solution was incubated at 4°C for a further 90 min. Finally, the im- 
munoprecipitates were washed three times in I lysis buffer and then 
solubilised in SDS-PAGE sample buffer. The proteins were transferred 
onto nitrocellulose membranes as described above. Biotinylated pro- 
teins were visualised by probing the blot using the avidin/biotin/HRP 
complexes (ABC kit (Vector)). 
3. Results 
3.1. The TolllOB receptor is expressed as a distinct isoJorm of  
slower electrophoretic mobillity 
The biogenesis of the wild type and Tol l l0B receptor mole- 
cules has been studied by inducing their expression in cell lines 
9A and SLTL10B, respectively. Expression was induced by 
subjecting the cells to heat shock and the receptor molecules 
were detected in cell lysates by Western blot (Fig. 1). A l though 
neither Toll transcript is translated efficiently during the period 
of heat shock low levels of protein can be detected. In 9A cells 
the wild type receptor is present as an isoform of approximately 
135 kDa but by contrast he Tol l l0B receptor is seen mainly 
as a slower mobil ity species (ca. 150 kDa). When the cells are 
returned to 26°C, translation of the mRNAs  is stimulated. In 
SLTL10B cells, Toll accumulates as a 150 kDa isoform during 
the recovery period. By contrast he wild type receptor contin- 
ues to be expressed as the 135 kDa form but can now also be 
detected as a species with the same mobil ity as the Tol l l0B 
receptor. 
3.2. The 135 and 150 kDa isoforms of  Toll are generated by 
N-linked glycosylation 
In order to determine whether the observed isoforms of Toll 
were a consequence of different patterns of glycosylation, ex- 
tracts of induced 9A and Tol l l0B cells were treated with a 
mixture of endoglycosidase F and glycopeptidase F which to- 
gether cleave all kinds of N-l inked carbohydrate from protein 
molecules. Such treatment converts both the 135 and 150 kDa 
isoforms of Toll into a single species of M r 120 kDa (Fig. 2), 
a mass consistent with that predicted by the cDNA sequence 
of Toll [8]. This result shows that the different isoforms of Toll 
observed in 9A and SLTL10B cells are caused by differential 
patterns of asparagine linked glycosylation and that the 
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Fig. 1. Time course of Toll expression i  stably transfected cells. Toll expression i SLTL 10B and 9A cells was monitored uring heat shock at 37°C 
for 30 min and during subsequent incubation at 26°C. Extracts were prepared at the indicated times and the protein detected by Western blot. The 
positions of molecular mass markers are shown (kDa). 
K. Kubota et al. IFEBS Letters 365 (1995) 83~86 85 
TL "~ + + 
Tfl °b + + 
Endo F/GPase F • - -  • -~- "l- - -  
205 
123 
~[= p150 p135 
89 
67 
50 
Fig. 2. Deglycosylation f Toll. Cell extracts were prepared from 9A 
and SLTL10B treated as described insection 2. Samples were fraction- 
ated by SDS-PAGE (7%) (2 × l0  6 cells/lane) and analysed by Western 
blot. The molecular mass of marker proteins i  indicated on the left in 
kDa. 
Tolll0B mutation (781Cys-Tyr) does not alter the electro- 
phoretic mobility of the Toll protein. We also find that Toll is 
unaffected by treatment with phospho-mono-esterases and 
does not incorporate radio-labelled palmitic acid (data not 
shown). Thus, it is unlikely that the Toll receptor is modified 
either by phosphorylation r by palmitoylation. 
3.3. The 135 kDa isoform of Toll predominates in the embryo 
In order to determine which forms of Toll are present in the 
embryo, we have probed carefully staged embryonic extracts by 
Western blot with anti-Toll antibodies. The Toll protein is seen 
to accumulate inthe embryo during the first two hours reaching 
a peak level at about 2.5 h of development, a finding that is 
consistent with previous reports [9,13]. It is also evident from 
this experiment that the 135 kDa form of Toll is predominant 
in the embryo (Fig. 3A). We have also examined the expression 
of the Toll receptor in extracts of embryos derived from moth- 
ers carrying one copy of the wild type Toll gene and one copy 
of Toll °B. As shown in Fig. 3B, only the smaller isoform of Toll 
is detected in extracts of wild-type embryos. By contrast, in 
extract of TolIIOB/+ embryos both isoforms are present. 
3.4. The TolllOB receptor is secreted normally to the cell surface 
It is possible that the different pattern of glycosylation dis- 
played by the TolIlOB receptor is caused by a failure of the 
mutant protein to be properly secreted to the cell surface. To 
investigate his possibility, we labelled cell surface proteins of 
9A and SLTL10B cells with NHS-biotin (see section 2.4). Toll 
was purified by immunoprecipitation andincorporation ofbio- 
tin into the receptor molecules was assayed in a Western blot 
procedure. As shown in Fig. 4, biotin was incorporated into the 
150 kDa protein on SLTLIOB cells and into both Toll isoforms 
in 9A with a ratio comparable with that observed in direct 
Western blot experiments ( ee Figs. 1,2). These results show 
that both forms of Toll are exported to the cell surface and that 
the differences observed are not the result of retention in the 
secretory pathway. 
4. Discussion 
In this paper we show that an activated form of the Droso- 
phila Toll receptor is processed into an isoform of slower elec- 
trophoretic mobility compared with the wild type protein. The 
different isoforms are generated by N-linked glycosylation be- 
cause after treatment with enzymes pecific for N-glycosides 
both forms are converted to a single species of the same electro- 
phoretic mobility. In Drosophila two types of glycosylation are 
known; N-linked and O-linked (see [14]). In N-linked glycosyl- 
ation, carbohydrates are linked to the amino nitrogen of aspar- 
agine, whereas in O-glycosylation carbohydrates are linked to 
the hydroxyl oxygen of serine, threonine, or hydroxyl ysine. 
N-glycosides are more commonly found in mammalian 
glycoproteins than O-glycosides, but a single glycoprotein may 
have multiple chains, some of which are O-glycosides and some 
of which are N-glycosides. For N-glycosylation, an oligosac- 
charide composed of 3 glucoses, 9 mannoses and 2 N-acetyl- 
glucosamines derived from a dolichol pyrophosphate precursor 
is added to an asparagine r sidue in a consensus sequence of 
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Fig. 3. (A) Toll protein in staged embryo extracts. Extracts from staged 
wild type embryos, 9A and SLTL10B were separated by 10% SDS- 
PAGE (100 ,ug/lane) and analysed by Western blot. The age of the 
extracts i indicated in hours. As a control, extract from 0-3 h embryos 
was probed with pre-immune s rum. The apparent molecular mass of 
the marker proteins is indicated in kDa. (B) Toll protein in TolllOBI+ 
embryos. Extract was prepared from (L4 h embryos as described in 
section 2. As a control, E. coli pETN3 protein (residues 18 806 of Toll 
(see [13]) was run (150 ng). 
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Fig. 4. Biotinylation of cell surface Toll protein. Expression of Toll was 
induced in 9A and SLTL10B by a 30 min heat shock. The cells were 
allowed to recover for 1 h and then labelled with NHS-biotin as de- 
scribed in section 2. Toll protein was purified by immunoprecipitation 
and separated by SDS-PAGE (7%). Biotinylated Toll was detected in 
a Western blot procedure. The apparent molecular mass of the marker 
proteins is indicated in kDa. 
Asn-X-Ser/Thr where X is any amino acid residue except pro- 
line or hydroxyproline [15,16]. Glycosylation takes place nor- 
mally as the protein is being synthesised at the luminal side of 
the endoplasmic reticulum (ER). Mannose residues are gradu- 
ally trimmed off in the ER and the Golgi apparatus as the 
protein is conveyed through the secretory pathway. At the 
Golgi apparatus ialic acids can be added to the processed 
glycosides moiety. 
Our findings can be explained in terms of a failure of the 
trimming reaction in the Golgi apparatus. For example over- 
expression might saturate the trimming enzymes and allow 
unprocessed receptor to be secreted. However, this seems un- 
likely as the TolI10B receptor is over glycosylated even when 
expressed at low levels and forms into a completely distinct 
isoform. Alternatively, the Tolll0B receptor might adopt a dis- 
tinct conformation that makes available additional glycosyla- 
tion sites that are not accessible in the wild type receptor. 
However, the wild type receptor can be glycosylated to the 
same extent as Tolll0B when overexpressed. This finding sug- 
gests either that the additional sites are masked by a titratable 
co-factor or alternatively that binding of a limiting co-factor 
induces a conformational change in the receptor which makes 
a subset of glycosylation sites inaccessible to the modifying 
enzymes. Such a model predicts that Tolll0B is unable to asso- 
ciate with this co-factor and that association of the receptor 
with the co-factor occurs during biogenesis and secretion. The 
wild type Toll receptor is known to function as a heterotypic 
cell adhesion molecule in SL2 cells [5] and thus it is likely that 
these cells produce ligands that can bind specifically to the 
extracellular domain of the receptor. It is also possible that 
specific factors required for the intra-cellular signalling path- 
way bind to the cytoplasmic sequence of Toll and cause a 
structural change in the extracellular domain. A candidate for 
such a factor is the dorsal group protein tube which may pro- 
vide a link between the receptor and activation pelle, a protein 
kinase of the raf family [17]. 
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